Population
Cultured bovine aortic endothelial (BAE) cells
Comparison
Medroxyprogesterone acetate at 10 M, 10 M, 10 M… vs bFGF alone or control medium
Design
Preclinical
Authors
Loading...
Experimental data link MPA to PAI-1-mediated angiogenesis suppression; leaves open clinical translation in vascular disease.
Angiostatic steroids such as medroxyprogesterone acetate inhibit angiogenesis by increasing PAI-1 synthesis, thereby suppressing plasminogen activator activity.
Blei et al. (1993) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: